Schmid G, Zilg H, Johannsen R
Cell Culture Development Group, Behringwerke AG, Marburg, Federal Republic of Germany.
Appl Microbiol Biotechnol. 1992 Dec;38(3):328-33. doi: 10.1007/BF00170081.
Anchorage-dependent human antithrombin III-producing recombinant baby hamster kidney (rBHK) cells were cultivated on Cytodex 3 microcarriers in repeated batch mode. During a 3-month experiment four different low-serum (0.025% fetal bovine serum) or serum-free medium formulations were evaluated for (a) the initial growth phase of cells and (b) the subsequent production phase, whereby two free fatty acid (FFA) supplements were examined with respect to their growth-promoting and product-formation-enhancing properties. Selected nutrient and (by)product consumption and production rates (including those for antithrombin III, amino acids, and fatty acids) are reported. The calculated metabolic quotients reflect the prevailing slow growth conditions (mu approx. 0.06 day-1) associated with microcarrier cultures. Specific antithrombin III productivities vary significantly as a function of the feed medium supplementation with FFA.
依赖贴壁的产人抗凝血酶III重组幼仓鼠肾(rBHK)细胞在Cytodex 3微载体上以重复批次模式培养。在为期3个月的实验中,评估了四种不同的低血清(0.025%胎牛血清)或无血清培养基配方在(a)细胞的初始生长阶段和(b)随后的生产阶段的效果,同时研究了两种游离脂肪酸(FFA)补充剂对细胞生长促进和产物形成增强特性的影响。报告了选定的营养物质和(副)产物的消耗及生产率(包括抗凝血酶III、氨基酸和脂肪酸的消耗及生产率)。计算得到的代谢商反映了与微载体培养相关的普遍缓慢生长条件(μ约为0.06天-1)。抗凝血酶III的比生产率随FFA对进料培养基的补充情况而有显著差异。